Title: Metabolic syndrone and it’s components as a risk factors of dementia

Biography:

Carol Routledge is the Director of Research at Alzheimer’s Research UK where she currently drives the research agenda. Carol has moved to ARUK from the Dementia Discovery Fund, where she was a Venture Partner with a key focus on identifying and developing novel disease-modifying mechanisms for the treatment of all types of dementia, sourcing opportunities from academic research groups and small companies.

Abstract

TBA